11beta,13-dihydrodesacylcynaropicrin
ID: ALA5172465
PubChem CID: 12047617
Max Phase: Preclinical
Molecular Formula: C15H20O4
Molecular Weight: 264.32
Associated Items:
This compound is not in our inventory system
ID: ALA5172465
PubChem CID: 12047617
Max Phase: Preclinical
Molecular Formula: C15H20O4
Molecular Weight: 264.32
Associated Items:
Canonical SMILES: C=C1[C@@H]2[C@H]3OC(=O)[C@@H](C)[C@@H]3[C@@H](O)CC(=C)[C@@H]2C[C@@H]1O
Standard InChI: InChI=1S/C15H20O4/c1-6-4-11(17)13-8(3)15(18)19-14(13)12-7(2)10(16)5-9(6)12/h8-14,16-17H,1-2,4-5H2,3H3/t8-,9-,10-,11-,12-,13+,14+/m0/s1
Standard InChI Key: AEWOONBLAKEKSC-CLSQCYNNSA-N
Molfile:
RDKit 2D 23 25 0 0 0 0 0 0 0 0999 V2000 -2.4008 0.5659 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.5758 0.5659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0810 1.2372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2939 0.9900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4428 1.8014 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.2939 0.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.1025 -0.0912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3160 -0.8881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4457 -0.6506 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.3518 -0.3530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5346 0.4514 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1.1539 -0.1697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5109 0.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1534 1.3152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3518 1.4987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1382 2.2956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3360 0.5774 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.9783 -0.1365 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1.5758 -0.8958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.0450 -1.4987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2867 -1.1687 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.2585 -2.2956 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.4008 -0.8958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 3 2 1 0 4 3 1 0 4 5 1 6 4 6 1 0 6 7 1 0 7 2 1 0 7 8 2 0 6 9 1 6 6 10 1 0 10 11 1 1 12 10 1 0 13 12 1 0 14 13 1 0 15 14 1 0 4 15 1 0 15 16 2 0 13 17 1 6 12 18 1 6 12 19 1 0 19 20 1 0 21 20 1 0 10 21 1 0 20 22 2 0 19 23 1 6 M END
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 264.32 | Molecular Weight (Monoisotopic): 264.1362 | AlogP: 1.04 | #Rotatable Bonds: ┄ |
Polar Surface Area: 66.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 0.36 | CX LogD: 0.36 |
Aromatic Rings: ┄ | Heavy Atoms: 19 | QED Weighted: 0.51 | Np Likeness Score: 3.57 |
1. Tanaka N, Yoshino Y, Nakano F, Kurimoto SI, Kawazoe K, Tsuji D, Itoh K, Li SL, Sun HD, Takaishi Y, Kashiwada Y.. (2022) Lanicepines A and B, Sesquiterpenes with Amino Acid-Derived Substituents from the Flowering Aerial Parts of Saussurea laniceps., 85 (4.0): [PMID:35179378] [10.1021/acs.jnatprod.1c01069] |
Source(1):